Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D
Clinical trial NCT05847413 · COMPLETED
Trial details
- NCT number
- NCT05847413
- Sponsor
- Benaroya Research Institute
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-30
- Primary completion
- 2021-12-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.